John R. Plachetka
Keine laufenden Positionen mehr
Profil
John R.
Plachetka was the founder who founded POZEN, Inc. in 1996, where he held the titles of Chairman, President & Chief Executive Officer from 2011 to 2015.
He was also the President & Chief Executive Officer of Clinical Research Foundation-America from 1990 to 1992 and the Vice President-Development of Encysive Pharmaceuticals, Inc. from 1993 to 1995.
Additionally, he worked as a Director-Cardiovascular Clinical Research at Glaxo, Inc. Dr. Plachetka holds a doctorate from the University of Missouri-Kansas City and an undergraduate degree from UIC College of Pharmacy.
Ehemalige bekannte Positionen von John R. Plachetka
| Unternehmen | Position | Ende |
|---|---|---|
| POZEN INC. | Vorstandsvorsitzender | 01.06.2015 |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01.01.1995 |
| Clinical Research Foundation-America | Präsident | 01.01.1992 |
| Glaxo, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von John R. Plachetka
| University of Missouri-Kansas City | Doctorate Degree |
| UIC College of Pharmacy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology POZEN, Inc. manufactures and markets pharmaceutical products. Its Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. The firm PA Product Portfolio consists of PA8140 and PA32540. The company was founded by John R. Plachetka in 1996 and is headquartered in Raleigh, NC. | Health Technology |
| Glaxo, Inc. | |
| Clinical Research Foundation-America |
